Skip to main content

Table 1 Participant characteristics for 1466 lung cancer survivors by Baecke physical activity data

From: Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship

Participant characteristic

Non-physically active (N = 331)

Physically active (N = 1135)

Total (N = 1466)

Age at diagnosis

   

  N

331

1135

1466

 Mean (SD)

68.7 (9.73)

64.9 (10.82)

65.7 (10.7)

 Range

(35.0–91.0)

(18.0–93.0)

(18–93)

Gender

   

 Female

158 (47.7 %)

568 (50 %)

726 (49.5 %)

 Male

173 (52.3 %)

567 (50 %)

740 (50.5 %)

Race

   

 Caucasian

311 (94 %)

1059 (93.3 %)

1370 (93.5 %)

 Hispanic

4 (1.2 %)

8 (0.7 %)

12 (0.8 %)

 Alaskan/Indian

15 (4.5 %)

54 (4.8 %)

69 (4.7 %)

 Black

1 (0.3 %)

3 (0.3 %)

4 (0.3 %)

 Asian/Pacific Islander

0 (0.0 %)

6 (0.5 %)

6 (0.4 %)

 Unknown

0 (0.0 %)

5 (0.4 %)

5 (0.3 %)

Years of schooling completed

   

 N

67

307

374

 Mean (SD)

13.0 (2.35)

13.6 (2.41)

13.5 (2.4)

 Range

(6.0–17.0)

(5.0–18.0)

(5.0–18.0)

Marital status

   

 Missing

62

185

247

 Single

9 (3.3 %)

47 (4.9 %)

56 (4.6 %)

 Married

194 (72.1 %)

751 (79.1 %)

945 (77.5 %)

 Divorced

27 (10 %)

75 (7.9 %)

102 (8.4 %)

 Widowed

39 (14.5 %)

75 (7.9 %)

114 (9.4 %)

 Life partner

0 (0.0 %)

2 (0.2 %)

2 (0.2 %)

Vital status (as of 2/2010)

   

 Alive

167 (50.5 %)

787 (69.3 %)

954 (65.1 %)

 Dead

164 (49.5 %)

348 (30.7 %)

512 (34.9 %)

Time to last FU (as of 2/2010) in years

   

 N

331

1135

1466

 Mean (SD)

2.7 (2.15)

3.3 (2.43)

3.1 (2.38)

 Range

(0.1–8.6)

(0.0–9.0)

2.2

Cigarette smoking status

   

 Never

36 (10.9 %)

218 (19.2 %)

254 (17.3 %)

 Former smoker

165 (49.8 %)

615 (54.2 %)

780 (53.2 %)

 Current smoker

129 (39 %)

294 (25.9 %)

423 (28.9 %)

 Some smoking history

1 (0.3 %)

8 (0.7 %)

9 (0.6 %)

Pack-Years

   

 N

292

910

1202

 Mean (SD)

53.2 (34.44)

45.4 (28.29)

47.3 (30.07)

 Range

(0.5–208.0)

(0.0–180.0)

(0.0–208.0)

Condensed grade

   

 Missing

1

6

7

 1 = Well differentiated

58 (17.6 %)

328 (29.1 %)

386 (26.5 %)

 2 = Moderately differentiated

104 (31.5 %)

414 (36.7 %)

518 (35.5 %)

 3 = Poorly differentiated

142 (43 %)

321 (28.4 %)

463 (31.7 %)

 4 = Non-gradeable

26 (7.9 %)

66 (5.8 %)

92 (6.3 %)

Stage

   

 Missing

6

5

11

 Limited

27 (8.3 %)

36 (3.2 %)

63 (4.3 %)

 Extensive

22 (6.8 %)

30 (2.7 %)

52 (3.6 %)

 Stage IA

49 (15.1 %)

320 (28.3 %)

369 (25.4 %)

 Stage IB

48 (14.8 %)

186 (16.5 %)

234 (16.1 %)

 Stage IIA

6 (1.8 %)

24 (2.1 %)

30 (2.1 %)

 Stage IIB

17 (5.2 %)

68 (6 %)

85 (5.8 %)

 Stage IIIA

42 (12.9 %)

124 (11 %)

166 (11.4 %)

 Stage IIIB

45 (13.8 %)

116 (10.3 %)

161 (11.1 %)

 Stage IV

69 (21.2 %)

226 (20 %)

295 (20.3 %)

T (tumor) of TNM staging

   

 Missing

69

176

245

 No primary tumor

6(2.3 %)

10(1.0 %)

16(1.3 %)

 Tumor < = 3 cm

83 (31.7 %)

420 (43.8 %)

503 (41.2 %)

 Tumor > 3 cm

92 (35.1 %)

309 (32.2 %)

401 (32.8 %)

 Invades chest wall

14 (5.3 %)

54 (5.6 %)

68 (5.6 %)

 Invades mediastinum

56 (21.4 %)

137 (14.3 %)

193 (15.8 %)

 Cannot be assessed

11 (4.2 %)

29 (3 %)

40 (3.3 %)

N (nodes) of TNM staging

   

 Missing

51

123

174

 No nodal mets

122 (43.6 %)

611 (60.4 %)

733 (56.7 %)

 In Peribr/Hilar

30 (10.7 %)

98 (9.7 %)

128 (9.9 %)

 In Medias/Subcarinal

97 (34.6 %)

210 (20.8 %)

307 (23.8 %)

 Mets in contralaterl

22 (7.9 %)

76 (7.5 %)

98 (7.6 %)

 Nodes Unassessable

9 (3.2 %)

17 (1.7 %)

26 (2 %)

Surgery

   

 Missing

12

27

39

 No

179 (56.1 %)

381 (34.4 %)

560 (39.2 %)

 Yes

140 (43.9 %)

727 (65.6 %)

867 (60.8 %)

Surgery within 6 months

   

 Missing

12

27

39

 No

189 (59.2 %)

435 (39.3 %)

624 (43.7 %)

 Yes

130 (40.8 %)

673 (60.7 %)

803 (56.3 %)

Chemotherapy

   

 Missing

12

27

39

 No

120 (37.6 %)

542 (48.9 %)

662 (46.4 %)

 Yes

199 (62.4 %)

566 (51.1 %)

765 (53.6 %)

Chemotherapy within 6 months

   

 Missing

12

27

39

 No

166 (52 %)

686 (61.9 %)

852 (59.7 %)

 Yes

153 (48 %)

422 (38.1 %)

575 (40.3 %)

Radiation

   

 Missing

12

27

39

 No

193 (60.5 %)

769 (69.4 %)

962 (67.4 %)

 Yes

126 (39.5 %)

339 (30.6 %)

465 (32.6 %)

Radiation within 6 months

   

 Missing

12

27

39

 No

230 (72.1 %)

875 (79 %)

1105 (77.4 %)

 Yes

89 (27.9 %)

233 (21 %)

322 (22.6 %)